Patents by Inventor Armin Meinzer

Armin Meinzer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions comprising cyclosporins
    Patent number: 5962017
    Abstract: Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or ?Nva!.sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight mono- or poly-oxy-alkane diol, e.g. Transcutol or Glycofurol, as hydrophilic component. Compositions are also provided comprising a cyclosporin and (1.1) and, suitably, also a saccharide monoester, e.g. raffinose or saccharose monolaurate. Dosage forms include topical formulations and, in particular, oral dosage forms.
    Type: Grant
    Filed: February 17, 1998
    Date of Patent: October 5, 1999
    Assignee: Novartis G
    Inventors: Birgit Hauer, Armin Meinzer, Ulrich Posanski, Friedrich Richter
  • Galenical formulations
    Patent number: 5932243
    Abstract: A pharmaceutical composition containing macrolide, e.g. a rapamycin compound in an emulsion preconcentrate or microemulsion preconcentrate for oral administration. The carrier medium for the rapamycin compound includes a hydrophilic phase, a lipophilic phase and a surfactant. The composition is stable and provides high absorption efficiency.
    Type: Grant
    Filed: August 22, 1997
    Date of Patent: August 3, 1999
    Assignee: Novartis AG
    Inventors: Gerd Fricker, Barbara Haeberlin, Armin Meinzer, Jacky Vonderscher
  • Pharmaceutical compositions comprising cyclosporins
    Patent number: 5916589
    Abstract: Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or ?Nva!.sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight mono- or poly-oxy-alkane diol, e.g. Transcutol or Glycofurol, as hydrophilic component. Compositions are also provided comprising a cyclosporin and (1.1) and, suitably, also a saccharide monoester, e.g. raffinose or saccharose monolaurate. Dosage forms include topical formulations and, in particular, oral dosage forms.
    Type: Grant
    Filed: March 6, 1997
    Date of Patent: June 29, 1999
    Assignee: Novartis AG
    Inventors: Birgit Hauer, Armin Meinzer, Ulrich Posanski, Friedrich Richter
  • Pharmaceutical compositions comprising cyclosporins
    Patent number: 5866159
    Abstract: Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or ?Nva!.sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight mono- or poly-oxy-alkane diol, e.g. Transcutol or Glycofurol, as hydrophilic component. Compositions are also provided comprising a cyclosporin and (1.1) and, suitably, also a saccharide monoester, e.g. raffinose or saccharose monolaurate. Dosage forms include topical formulations and, in particular, oral dosage forms.
    Type: Grant
    Filed: March 6, 1997
    Date of Patent: February 2, 1999
    Assignee: Novartis AG
    Inventors: Birgit Hauer, Armin Meinzer, Ulrich Posanski, Friedrich Richter
  • Pharmaceutical compositions comprising cyclosporins
    Patent number: 5741512
    Abstract: Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or ?Nva!.sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight mono- or poly-oxy-alkane diol, e.g. Transcutol or Glycofurol, as hydrophilic component. Compositions are also provided comprising a cyclosporin and (1.1) and, suitably, also a saccharide monoester, e.g. raffinose or saccharose monolaurate. Dosage forms include topical formulations and, in particular, oral dosage forms.
    Type: Grant
    Filed: April 27, 1995
    Date of Patent: April 21, 1998
    Assignee: Novartis Corporation
    Inventors: Birgit Hauer, Armin Meinzer, Ulrich Posanski, Friedrich Richter
  • Pharmaceutical compositions comprising cyclosporins
    Patent number: 5342625
    Abstract: Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight mono- or poly-oxy-alkane diol, e.g. Transcutol or Glycofurol, as hydrophilic component. Compositions are also provided comprising a cyclosporin and (1.1) and, suitably, also a saccharide monoester, e.g. raffinose or saccharose monolaurate. Dosage forms include topical formulations and, in particular, oral dosage forms.
    Type: Grant
    Filed: December 15, 1992
    Date of Patent: August 30, 1994
    Assignee: Sandoz Ltd.
    Inventors: Birgit Hauer, Armin Meinzer, Ulrich Posanski, Friedrich Richter